YUMAB GmbH is a German biotechnology company specializing in contract research for the discovery and development of fully human therapeutic antibodies. They provide antibody discovery, engineering, humanization, and characterization services using proprietary human-derived antibody libraries (>10^11) and in-vitro selection technology.
Almost 30 years of expertise in antibody research. Proprietary human-derived universal antibody libraries, powerful in-vitro and cell-based selection technology, high-throughput screening, and antibody engineering by in-vitro evolution and bioinformatic design. Compatible with all antibody formats and difficult targets.
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.